Rapid Transport and Infusion of Hematopoietic Cells Is Associated with Improved Outcome after Myeloablative Therapy and Unrelated Donor Transplant

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 5, 2009, Pages 589-596

  Lazarus, Hillard M ^a   Kan, Fangyu ^b   Tarima, Sergey ^c   Champlin, Richard E ^d   Confer, Dennis L ^b   Frey, Noelle ^e   Gee, Adrian P ^f   Wagner, John E ^g   Horowitz, Mary M ^c   Eapen, Mary ^c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b NATIONAL MARROW DONOR PROGRAM   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Transplant outcomes; Transport of unrelated donor grafts; Transport times

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FLUDARABINE; MELPHALAN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC LEUKEMIA; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HLA MATCHING; HUMAN; HUMAN CELL; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS; THROMBOCYTE; TREATMENT OUTCOME;

BIOLOGICAL SPECIMEN BANKS; BONE MARROW TRANSPLANTATION; DATA COLLECTION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; LEUKEMIA; MALE; MYELOABLATIVE AGONISTS; MYELODYSPLASTIC SYNDROMES; ODDS RATIO; TIME FACTORS; TISSUE DONORS; TRANSPORTATION; TREATMENT OUTCOME;

EID: 63749091853     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.01.017     Document Type: Article

References (25)

1. Tabbara I.A., Zimmerman K., Morgan C., and Nahleh Z. Allogeneic hematopoietic stem cell transplantation: complications and results. Arch Intern Med 162 (2002) 1558-1566
2. Hansen J.A., and Petersdorf E.W. Unrelated donor hematopoietic cell transplantation. Hematopoietic Cell Transplantation. 2nd ed. (1999), Blackwell Science, Malden, MA 915-928
3. Anasetti C., Petersdorf E.W., Martin P.J., Woolfrey A., and Hansen J.A. Improving availability and safety of unrelated donor transplants. Curr Opin Oncol 12 (2000) 121-126
4. Hurley C.K., Wagner J.E., Setterholm M.I., and Confer D.L. Advances in HLA: practical implications for selecting adult donors and cord blood units. Biol Blood Marrow Transplant 12 (2006) 28-33
5. Lee S.J., Klein J., Haagenson M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 110 (2007) 4576-4583
6. Gratwohl A., Baldomero H., Frauendorfer K., and Urbano-Ispizua A. EBMT activity survey 2004 and changes in disease indication over the past 15 years. Bone Marrow Transplant 37 (2006) 1069-1085
7. Karanes C., Confer D., Walker T., Askren A., and Keller C. Unrelated donor stem cell transplantation: the role of the National Marrow Donor Program. Oncology (Williston Park) 17 (2003) 1036-1038 1043-1044, 1164-1067
8. Farag S.S., Bacigalupo A., Eapen M., et al. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry. Biol Blood Marrow Transplant 12 (2006) 876-884
9. Flowers M.E., Kansu E., and Sullivan K.M. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am 13 (1999) 1091-1112 viii-ix
10. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18 (1974) 295-304
11. Kaplan E. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
12. Klein J., and Moeschberger M. Survival Analysis: Techniques of Censored and Truncated Aata (2003), Springer-Verlag, New York
13. Cox D.R. Regression models and life tables. J R Stat Soc 34 (1972) 187
14. Weisdorf D., Spellman S., Haagenson M., et al. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant 14 (2008) 748-758
15. Haddad S.A., Lichtiger B., and Klein H.G. In vivo efficacy of shipped HLA-matched platelets. Transfusion 46 (2006) 1306-1310
16. Food and Drugs, 21 C.F.R. Section.600.20. 2003.
17. Lazarus H.M., Pecora A.L., Shea T.C., et al. CD34+ selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4 degrees C does not affect outcome. Bone Marrow Transplant 25 (2000) 559-566
18. Fedorov N.I. Viability at various time intervals of cadaver bone marrow. Fed Proc Transl Suppl 25 (1966) 975-977
19. Lavrik S.S., Glukhen'kaia G.T., Karabanova L.L., Keisevich L.V., and Kogut G.I. [Long-distance transportation of preserved donor and cadaveric bone marrow]. Probl Gematol Pereliv Krovi 19 (1974) 58-61
20. Spitzer T.R., Areman E.M., Cirenza E., et al. The impact of harvest center on quality of marrows collected from unrelated donors. J Hematother 3 (1994) 65-70
21. Elliott C., and McCarthy D. A survey of methods of processing and storage of bone marrow and blood stem cells in the EBMT. Bone Marrow Transplant 14 (1994) 419-423
22. Preti R.A., Razis E., Ciavarella D., et al. Clinical and laboratory comparison study of refrigerated and cryopreserved bone marrow for transplantation. Bone Marrow Transplant 13 (1994) 253-260
23. Guidelines for the collection, processing and storage of human bone marrow and peripheral stem cells for transplantation. Prepared by the BCSH Blood Transfusion Task Force. Transfus Med 4 (1994) 165-172
24. Soderdahl G., Tammik C., Remberger M., and Ringden O. Cadaveric bone marrow and spleen cells for transplantation. Bone Marrow Transplant 21 (1998) 79-84
25. Lioznov M., Dellbrugger C., Sputtek A., Fehse B., Kroger N., and Zander A.R. Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM. Bone Marrow Transplant 42 (2008) 121-128